Faculty of Medicine, Department of Microbiology and Infectious Diseases, University of Calgary Health Sciences Centre, 3330 Hospital Dr. NW, Calgary, Alberta, Canada.
Exp Parasitol. 2010 Nov;126(3):366-80. doi: 10.1016/j.exppara.2010.03.005. Epub 2010 Mar 19.
Amebiasis is the disease caused by the enteric dwelling protozoan parasite Entamoeba histolytica. The WHO considers amebiasis as one of the major health problems in developing countries; it is surpassed by only malaria and schistosomiasis for death caused by parasitic infection. E. histolytica primarily lives in the colon as a harmless commensal, but is capable of causing devastating dysentery, colitis and liver abscess. What triggers the switch to a pathogenic phenotype and the onset of disease is unknown. We are becoming increasingly aware of the complexity of the host-parasite interaction. During chronic stages of amebiasis, the host develops an immune response that is incapable of eliminating tissue resident parasites, while the parasite actively immunosuppresses the host. However, most individuals with symptomatic infections succumb only to an episode of dysentery. Why most halt invasion and a minority progress to chronic disease remains poorly understood. This review presents a current understanding of the immune processes that shape the outcome of E. histolytica infections during its different stages.
溶组织内阿米巴病是由肠道居住的原生动物寄生虫溶组织内阿米巴引起的疾病。世界卫生组织认为溶组织内阿米巴病是发展中国家的主要健康问题之一;它仅因寄生虫感染导致的死亡而次于疟疾和血吸虫病。溶组织内阿米巴主要作为无害共生体生活在结肠中,但能够引起毁灭性的痢疾、结肠炎和肝脓肿。触发向致病表型转变和疾病发作的原因尚不清楚。我们越来越意识到宿主-寄生虫相互作用的复杂性。在溶组织内阿米巴病的慢性阶段,宿主会产生一种无法消除组织内寄生虫的免疫反应,而寄生虫则积极抑制宿主的免疫反应。然而,大多数有症状感染的个体仅因一次痢疾发作而屈服。为什么大多数人停止侵袭,而少数人进展为慢性疾病,仍知之甚少。这篇综述介绍了目前对免疫过程的理解,这些免疫过程塑造了溶组织内阿米巴在其不同阶段感染的结果。